ARK Genomic Revolution ETF
ARKG
40 hedge funds and large institutions have $19.9M invested in ARK Genomic Revolution ETF in 2018 Q1 according to their latest regulatory filings, with 23 funds opening new positions, 9 increasing their positions, 3 reducing their positions, and 1 closing their positions.
2,200% more first-time investments, than exits
New positions opened: 23 | Existing positions closed: 1
200% more repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 3
153% more capital invested
Capital invested by funds: $7.86M → $19.9M (+$12M)
122% more funds holding
Funds holding: 18 → 40 (+22)
3.31% more ownership
Funds ownership: 14.81% → 18.12% (+3.3%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$4.42M |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$1.66M |
| 3 |
Jane Street
New York
|
+$1.17M |
| 4 |
FA
FDx Advisors
Chicago,
Illinois
|
+$1.15M |
| 5 |
LPL Financial
San Diego,
California
|
+$675K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EFS
Edelman Financial Services
Fairfax,
Virginia
|
-$315K |
| 2 |
AF
Advisornet Financial
Minnetonka,
Minnesota
|
-$37K |
| 3 |
AG
Advisor Group
Phoenix,
Arizona
|
-$2.71K |
| 4 |
GFP
Gryphon Financial Partners
Columbus,
Ohio
|
-$433 |
ARKG Hedge Fund Activity: Q1 2018 in Review
40 of the 4,364 institutional investors tracked by Wall St. Rank reported a position in ARK Genomic Revolution ETF (ARKG) for Q1 2018, worth a combined $19.9M — up 153% from $7.86M a quarter earlier.
Buyers outnumbered sellers: 23 funds opened new ARKG positions and 1 closed out — a net gain of 22 holders — while 9 added to existing stakes and 3 trimmed.
The largest buyer was Morgan Stanley, adding an estimated $4.42M. The largest seller was Edelman Financial Services, cutting an estimated $315K.
- 40 institutional investors held ARK Genomic Revolution ETF (ARKG) as of Q1 2018, up from 18 in Q4 2017.
- Funds reported $19.9M of ARK Genomic Revolution ETF stock for Q1 2018, up 153% quarter-over-quarter.
- 23 funds opened new ARK Genomic Revolution ETF positions in Q1 2018 and 1 closed out, a net change of +22 holders.
- The largest ARK Genomic Revolution ETF buyer in Q1 2018 was Morgan Stanley, an estimated $4.42M added.
- The largest ARK Genomic Revolution ETF seller in Q1 2018 was Edelman Financial Services, an estimated $315K sold.
Based on aggregated 13F filings for Q1 2018.